China National Chemical Corporation
http://www.chemchina.com.cn/en/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From China National Chemical Corporation
Bone Therapeutics names new CFO
Wim Geomaere
Deals Shaping The Medical Industry, September 2012
The Dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, medical devices, pharmaceuticals, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.
Medical Device Deals Update, August 2012
A roundup of recent medtech mergers & acquisitions, strategic alliances, and financings.
Start-Up Quarterly Statistics, Q3 2011
Biopharma start-ups raised $299 million and just over half were Series A rounds. Device companies brought in $134 million, while two diagnostics firms raised $10 million total. Ophthalmology was the most popular theracat for biopharma alliances. Just one acquisition involving a start-up took place.
Company Information
- Industry
- Diversified
- Other Names / Subsidiaries
-
- Devgen NV
- Syngenta International AG
- Floranova Ltd, State-owned Assets Supervision and Administration Commission
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice